Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.
2.

New monoclonal antibodies specific for mammalian protamines P1 and P2.

Balhorn R, Steger K, Bergmann M, Schuppe HC, Neuhauser S, Balhorn MC.

Syst Biol Reprod Med. 2018 Dec;64(6):424-447. doi: 10.1080/19396368.2018.1510063. Epub 2018 Aug 31.

PMID:
30169968
3.

Sperm nuclear protamines: A checkpoint to control sperm chromatin quality.

Steger K, Balhorn R.

Anat Histol Embryol. 2018 Aug;47(4):273-279. doi: 10.1111/ahe.12361. Epub 2018 May 23. Review.

PMID:
29797354
4.

Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.

Al Olaby RR, Cocquerel L, Zemla A, Saas L, Dubuisson J, Vielmetter J, Marcotrigiano J, Khan AG, Vences Catalan F, Perryman AL, Freundlich JS, Forli S, Levy S, Balhorn R, Azzazy HM.

PLoS One. 2014 Oct 30;9(10):e111333. doi: 10.1371/journal.pone.0111333. eCollection 2014.

5.

Identification of ligands that target the HCV-E2 binding site on CD81.

Olaby RA, Azzazy HM, Harris R, Chromy B, Vielmetter J, Balhorn R.

J Comput Aided Mol Des. 2013 Apr;27(4):337-46. doi: 10.1007/s10822-013-9649-3. Epub 2013 Apr 24.

PMID:
23612915
6.

Single molecule studies of DNA-protamine interactions.

Cree LH, Balhorn R, Brewer LR.

Protein Pept Lett. 2011 Aug;18(8):802-10.

PMID:
21443493
7.

Protamines. Editorial.

Balhorn MC, Balhorn R.

Protein Pept Lett. 2011 Aug;18(8):753-4. No abstract available.

PMID:
21443488
8.

Self-assembly of heptameric nanoparticles derived from tag-functionalized phi29 connectors.

Green DJ, Wang JC, Xiao F, Cai Y, Balhorn R, Guo P, Cheng RH.

ACS Nano. 2010 Dec 28;4(12):7651-9. doi: 10.1021/nn1024829. Epub 2010 Nov 16.

PMID:
21080706
9.

A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomas.

Balhorn RL, Skorupski KA, Hok S, Balhorn MC, Guerrero T, Rebhun RB.

Vet Immunol Immunopathol. 2010 Oct 15;137(3-4):235-42. doi: 10.1016/j.vetimm.2010.05.014. Epub 2010 Jun 2.

PMID:
20576295
10.

Time-dependent measure of a nanoscale force-pulse driven by the axonemal dynein motors in individual live sperm cells.

Allen MJ, Rudd RE, McElfresh MW, Balhorn R.

Nanomedicine. 2010 Aug;6(4):510-5. doi: 10.1016/j.nano.2009.12.003. Epub 2010 Jan 6.

PMID:
20060073
11.

Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells.

Balhorn R, Hok S, DeNardo S, Natarajan A, Mirick G, Corzett M, Denardo G.

Mol Cancer. 2009 Apr 22;8:25. doi: 10.1186/1476-4598-8-25.

12.

Raman spectroscopy of DNA packaging in individual human sperm cells distinguishes normal from abnormal cells.

Huser T, Orme CA, Hollars CW, Corzett MH, Balhorn R.

J Biophotonics. 2009 May;2(5):322-32. doi: 10.1002/jbio.200910012.

PMID:
19373853
13.

Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia.

DeNardo GL, Mirick GR, Hok S, DeNardo SJ, Beckett LA, Adamson GN, Balhorn RL.

Int J Oncol. 2009 Feb;34(2):511-6.

PMID:
19148487
14.

Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging.

DeNardo GL, Natarajan A, Hok S, Mirick G, DeNardo SJ, Corzett M, Sysko V, Lehmann J, Beckett L, Balhorn R.

Cancer Biother Radiopharm. 2008 Dec;23(6):783-96. doi: 10.1089/cbr.2008.0589.

15.

Identification of a thermo-regulated glutamine-binding protein from Yersinia pestis.

Cosman M, Pesavento JB, Zemla A, Beernink PT, Balhorn R, Barsky D.

Protein Pept Lett. 2008;15(9):887-94.

PMID:
18991762
16.

Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?

DeNardo GL, DeNardo SJ, Balhorn R.

Cancer Biother Radiopharm. 2008 Aug;23(4):383-97. doi: 10.1089/cbr.2007.0523-U.

17.

The protamine family of sperm nuclear proteins.

Balhorn R.

Genome Biol. 2007;8(9):227. Review.

18.

Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemia.

Balhorn R, Hok S, Burke PA, Lightstone FC, Cosman M, Zemla A, Mirick G, Perkins J, Natarajan A, Corzett M, DeNardo SJ, Albrecht H, Gregg JP, DeNardo GL.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5621s-5628s.

19.

Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.

Albrecht H, Cosman M, Ngu-Schwemlein M, Corzett M, Curran KW, Dolan C, Fang X, DeNardo SJ, DeNardo GL, Balhorn R.

Cancer Biother Radiopharm. 2007 Aug;22(4):531-42.

PMID:
17803448
20.

Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.

DeNardo GL, Hok S, Van Natarajan A, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Yuan A, Perkins J, Sysko VV, Lehmann J, Balhorn RL.

Int J Oncol. 2007 Oct;31(4):729-40.

21.

Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma.

DeNardo GL, Natarajan A, Hok S, Perkins J, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Miers LA, Balhorn RL.

J Nucl Med. 2007 Aug;48(8):1338-47. Epub 2007 Jul 13.

22.

Monitoring dynamic protein expression in living E. coli. Bacterial cells by laser tweezers Raman spectroscopy.

Chan JW, Winhold H, Corzett MH, Ulloa JM, Cosman M, Balhorn R, Huser T.

Cytometry A. 2007 Jul;71(7):468-74.

23.

Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia.

Hok S, Natarajan A, Balhorn R, DeNardo SJ, DeNardo GL, Perkins J.

Bioconjug Chem. 2007 May-Jun;18(3):912-21. Epub 2007 Mar 21.

PMID:
17373772
24.

Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells.

West J, Perkins J, Hok S, Balhorn R, Lightstone FC, Cosman M, DeNardo SJ, DeNardo GL.

Cancer Biother Radiopharm. 2006 Dec;21(6):645-54.

PMID:
17257080
25.

Electrospray mass spectrometry of NeuAc oligomers associated with the C fragment of the tetanus toxin.

Conway MCP, Whittal RM, Baldwin MA, Burlingame AL, Balhorn R.

J Am Soc Mass Spectrom. 2006 Jul;17(7):967-976. doi: 10.1016/j.jasms.2006.03.004. Epub 2006 May 19.

26.

Nonlinearly additive forces in multivalent ligand binding to a single protein revealed with force spectroscopy.

Ratto TV, Rudd RE, Langry KC, Balhorn RL, McElfresh MW.

Langmuir. 2006 Feb 14;22(4):1749-57.

PMID:
16460101
27.

Computational approaches for identification of conserved/unique binding pockets in the A chain of ricin.

Zhou CL, Zemla AT, Roe D, Young M, Lam M, Schoeniger JS, Balhorn R.

Bioinformatics. 2005 Jul 15;21(14):3089-96. Epub 2005 May 19.

PMID:
15905278
28.

Application of NMR methods to identify detection reagents for use in development of robust nanosensors.

Cosman M, Krishnan VV, Balhorn R.

Methods Mol Biol. 2005;300:141-63. Review.

PMID:
15657483
29.

Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Segelke B, Knapp M, Kadkhodayan S, Balhorn R, Rupp B.

Proc Natl Acad Sci U S A. 2004 May 4;101(18):6888-93. Epub 2004 Apr 23.

30.

Force spectroscopy of the double-tethered concanavalin-A mannose bond.

Ratto TV, Langry KC, Rudd RE, Balhorn RL, Allen MJ, McElfresh MW.

Biophys J. 2004 Apr;86(4):2430-7.

31.

Mechanism of DNA compaction by yeast mitochondrial protein Abf2p.

Friddle RW, Klare JE, Martin SS, Corzett M, Balhorn R, Baldwin EP, Baskin RJ, Noy A.

Biophys J. 2004 Mar;86(3):1632-9.

32.

Extracellular domain of myelin oligodendrocyte glycoprotein (MOG) exhibits solvent-dependent conformational transitions.

Ngu-Schwemlein M, Corzett M, Thornton KH, Balhorn R, Cosman M.

Protein Pept Lett. 2003 Oct;10(5):483-90. Erratum in: Protein Pept Lett. 2003 Dec;10(6):629.

PMID:
14561137
33.

Packaging of single DNA molecules by the yeast mitochondrial protein Abf2p.

Brewer LR, Friddle R, Noy A, Baldwin E, Martin SS, Corzett M, Balhorn R, Baskin RJ.

Biophys J. 2003 Oct;85(4):2519-24.

34.

Dynamics of protamine 1 binding to single DNA molecules.

Brewer L, Corzett M, Lau EY, Balhorn R.

J Biol Chem. 2003 Oct 24;278(43):42403-8. Epub 2003 Aug 11.

35.

Mass spectrometry and non-covalent protein-ligand complexes: confirmation of binding sites and changes in tertiary structure.

Shields SJ, Oyeyemi O, Lightstone FC, Balhorn R.

J Am Soc Mass Spectrom. 2003 May;14(5):460-70.

36.

Use of atomic force microscopy for morphological and morphometric analyses of acrosome intact and acrosome-reacted human sperm.

Mai A, Weerachatyanukul W, Tomietto M, Wayner DD, Wells G, Balhorn R, Leader A, Cyr JL, Tanphaichitr N.

Mol Reprod Dev. 2002 Dec;63(4):471-9.

PMID:
12412050
37.

Identification of novel small molecules that bind to two different sites on the surface of tetanus toxin C fragment.

Cosman M, Lightstone FC, Krishnan VV, Zeller L, Prieto MC, Roe DC, Balhorn R.

Chem Res Toxicol. 2002 Oct;15(10):1218-28.

PMID:
12387617
38.

Condensation of DNA by spermatid basic nuclear proteins.

Brewer L, Corzett M, Balhorn R.

J Biol Chem. 2002 Oct 11;277(41):38895-900. Epub 2002 Jul 24.

39.

Combining constitutive materials modeling with atomic force microscopy to understand the mechanical properties of living cells.

McElfresh M, Baesu E, Balhorn R, Belak J, Allen MJ, Rudd RE.

Proc Natl Acad Sci U S A. 2002 Apr 30;99 Suppl 2:6493-7.

40.

Protamine 1: protamine 2 stoichiometry in the sperm of eutherian mammals.

Corzett M, Mazrimas J, Balhorn R.

Mol Reprod Dev. 2002 Apr;61(4):519-27.

PMID:
11891924
41.

Processive translocation and DNA unwinding by individual RecBCD enzyme molecules.

Bianco PR, Brewer LR, Corzett M, Balhorn R, Yeh Y, Kowalczykowski SC, Baskin RJ.

Nature. 2001 Jan 18;409(6818):374-8.

PMID:
11201750
42.
43.

Zinc is sufficiently abundant within mammalian sperm nuclei to bind stoichiometrically with protamine 2.

Bench G, Corzett MH, Kramer CE, Grant PG, Balhorn R.

Mol Reprod Dev. 2000 Aug;56(4):512-9.

PMID:
10911401
44.

Cloning, expression, and one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A.

Kadkhodayan S, Knapp MS, Schmidt JJ, Fabes SE, Rupp B, Balhorn R.

Protein Expr Purif. 2000 Jun;19(1):125-30.

PMID:
10833399
45.

DNA condensation by protamine and arginine-rich peptides: analysis of toroid stability using single DNA molecules.

Balhorn R, Brewer L, Corzett M.

Mol Reprod Dev. 2000 Jun;56(2 Suppl):230-4.

PMID:
10824973
46.

Identification of novel small molecule ligands that bind to tetanus toxin.

Lightstone FC, Prieto MC, Singh AK, Piqueras MC, Whittal RM, Knapp MS, Balhorn R, Roe DC.

Chem Res Toxicol. 2000 May;13(5):356-62.

PMID:
10813652
47.
48.

Protamine-induced condensation and decondensation of the same DNA molecule.

Brewer LR, Corzett M, Balhorn R.

Science. 1999 Oct 1;286(5437):120-3.

49.

Analysis of hamster protamines: primary sequence and species distribution.

Corzett M, Kramer C, Blacher R, Mazrimas J, Balhorn R.

Mol Reprod Dev. 1999 Nov;54(3):273-82.

PMID:
10497349
50.

Protein and DNA contents in sperm from an infertile human male possessing protamine defects that vary over time.

Bench G, Corzett MH, De Yebra L, Oliva R, Balhorn R.

Mol Reprod Dev. 1998 Jul;50(3):345-53.

PMID:
9621311

Supplemental Content

Loading ...
Support Center